The Pemphigus Vulgaris Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
What are the Historical Growth Trends in the Pemphigus Vulgaris Market?
The market size for pemphigus vulgaris has seen significant growth recently. The market value increased from $1.80 billion in 2024 to $1.95 billion in 2025, with a compound annual growth rate (CAGR) of 8.1%.
What are the 2025 Market Projections: Forecasted Size & Growth Rate for the Pemphigus Vulgaris Industry?
The Pemphigus Vulgaris market is projected to reach $2.63 billion in 2029, with a compound annual growth rate (CAGR) of 7.8%.
Download Your Free Sample of the 2025 Pemphigus Vulgaris Market Report and Uncover Key Trends Now!
What are the Key Growth Drivers Fueling the Pemphigus Vulgaris Market?
The key drivers in the pemphigus vulgaris market are:
• Rise in clinical trials related to pemphigus vulgaris
• Growth in the field of precision medicine
• Increasing adoption of digital health solutions
• Surge in demand for biologics and telemedicine.
Global Market Segmentation: Identifying Major Pemphigus Vulgaris Industry Segments
The pemphigus vulgaris market covered in this report is segmented –
1) By Diagnosis And Treatment: Diagnosis, Treatment
2) By Population Type: Pediatric, Adults, Geriatric
3) By Distribution Channel: Hospitals Pharmacy, Retail Pharmacy, Online Pharmacy
4) By End-User: Hospitals, Specialty Clinics, Research Institutes, Other End-Users
Subsegments:
1) By Diagnosis: Clinical Examination, Skin Biopsy, Direct Immunofluorescence, Serological Tests, Polymerase Chain Reaction (PCR)
2) By Treatment: Pharmacological Therapy, Non-Pharmacological Therapy
Pre-order the 2025 Pemphigus Vulgaris Global Market Report for Fast Delivery & Comprehensive Insights!
What are the emerging Trends Shaping the Future of the Pemphigus Vulgaris Market?
The key trends in the pemphigus vulgaris market are:
• The market is anticipated to be driven by advancements in biologic therapies.
• Regulatory approval processes will significantly influence market trends.
• The adoption of combination therapies is emerging as a new trend.
• Development and innovation in personalized medicine and oral formulations of biologic therapies are key trending factors.
Who Are the Top Competitors & Leading Players in the Pemphigus Vulgaris Market?
Major players in the pemphigus vulgaris market are:
• Pfizer Inc.
• F. Hoffmann-La Roche Ltd
• Thermo Fisher Scientific Inc.
• GlaxoSmithKline plc
• Amgen Inc.
• Sanofi S.A
• Biogen Inc.
• Genentech
• Genmab A/S
• argenx SE
• Daewoong Pharmaceutical Co. Ltd.
• HanAll Biopharma Co. Ltd.
• Artiva Biotherapeutics
• Cabaletta Bio Inc.
• SinoMab BioScience Limited
• Topas Therapeutics GmbH
• Principia Biopharma Inc.
• Serpin Pharma LLC
• Syntimmune Inc.
• International Pemphigus & Pemphigoid Foundation
Regional Dominance: Which Area Leads the Global Template Market?
North America was the largest region in the pemphigus vulgaris market in 2024
